← Back
Data updated: Mar 29, 2026
AUROLIFE PHARMA LLC
CardiovascularGastroenterologyImmunology
Generics
AUROLIFE PHARMA LLC is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Immunology.
1972
Since
20
Drugs
-
Trials
686
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
METHADONE HYDROCHLORIDE 2026-01-22
Manufacturing (CMC)
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 25%
1 drugs
Gastroenterology 25%
1 drugs
Immunology 25%
1 drugs
Metabolic 25%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
QUAGEN specialty
Metabolic, Gastroenterology, Cardiovascular, Immunology
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
AstraZeneca big-pharma
Cardiovascular, Metabolic, Immunology
Active (10)
Discontinued (10)
OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE ACETAMINOPHEN AND CODEINE PHOSPHATE HYDROCODONE BITARTRATE AND IBUPROFEN CLORAZEPATE DIPOTASSIUM PHENTERMINE HYDROCHLORIDE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE DEXMETHYLPHENIDATE HYDROCHLORIDE CHLORPHENIRAMINE MALEATE
Company Info
- First Approval
- 1972-12-20
- Latest
- 2025-12-31
- Applications
- 30